Desmethyl cariprazine prodrug (Abbvie)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameDesmethyl cariprazine prodrug (Abbvie)
Drug Alias NameABBV-932RGH-932
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonistsDopamine D3 receptor agonists
TargetsDopamine D2 receptorDopamine D3 receptor
Therapy Area/IndicationsBipolar II DisorderBipolar I DisorderBipolar and Related Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie IncGedeon Richter Plc
Inactive CompaniesN/A
Active IndicationsBipolar II DisorderBipolar I DisorderBipolar and Related Disorders +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A